DSP Nifty Healthcare ETF
Summary Info
Fund Name
: DSP Mutual Fund
Scheme Name
: DSP Nifty Healthcare ETF
AMC
: DSP Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 11-Jan-2024
Fund Manager
: Anil Ghelani
Net Assets (Rs. cr)
: 18.12
DSP Nifty Healthcare ETF - Nav Details
Nav Date
: 08-Oct-2026
NAV [Rs.]
: 15.8368
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
DSP Nifty Healthcare ETF- NAV Chart
DSP Nifty Healthcare ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.55 | -5.67 | -2.78 | 11.6 | 8.9 | - | - | 13.12 |
| Category Avg | -1.18 | -6.28 | -4.34 | -1.83 | -0.57 | 11.75 | 8.42 | 7.21 |
| Category Best | 2.68 | 6.85 | 13.83 | 37.91 | 46.15 | 46.48 | 27.72 | 109.4 |
| Category Worst | -5.03 | -12.43 | -13.93 | -18.22 | -32.08 | -3.89 | -3.61 | -21.8 |
DSP Nifty Healthcare ETF- Latest Dividends
No Records Found
DSP Nifty Healthcare ETF- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 18.07 | 16496 | 3.27 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.34 | 1979 | 1.87 |
| Equity | Apollo Hospitals | Healthcare Services | 7.87 | 1603 | 1.42 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.82 | 8766 | 1.23 |
| Equity | Max Healthcare | Healthcare Services | 6.67 | 11593 | 1.20 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 6.41 | 6061 | 1.16 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 6.39 | 2285 | 1.15 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.05 | 9495 | 1.09 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 4.57 | 3783 | 0.82 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.09 | 4312 | 0.74 |
| Equity | Fortis Health. | Healthcare Services | 4.06 | 8117 | 0.73 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.21 | 2345 | 0.58 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.68 | 911 | 0.48 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.53 | 11113 | 0.45 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.50 | 3896 | 0.45 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.36 | 2164 | 0.42 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.35 | 1763 | 0.42 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.17 | 82 | 0.21 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.15 | 9689 | 0.20 |
| Equity | Syngene Intl. | Healthcare Services | 0.65 | 2960 | 0.11 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,47,696.08
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr. S. Ramadorai, Mr.Dhananjay Mungale, Uday Khanna
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Anil Ghelani
Auditors:
NA
OTHER INFORMATION
Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Email:
Website:
